Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Keywords
- Tumor Necrosis Factor
- Tumor Necrosis Factor Receptor
- Antiapoptotic Effect
- Nuclear Factor kappaB
- Human Pancreatic Cancer Cell Line
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Jacobson M. D., Weil M., Raff M. C.: Programmed cell death in animal development. Cell. 88:347–354, 1997
Darmon A. J., Nicholson D. W., Bleackley R. C.: Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature. 377:446–448, 1995
Shibata S., Kyuwa S., Lee S. K., Toyoda Y., Goto N.: Apoptosis induced in mouse hepatitis virus-infected cells by a virus-specific CD8+ cytotoxic T-lymphocyte clone. J Virol. 68:7540–7545, 1994
Jaattela M.: Escaping cell death: survival proteins in cancer. Exp Cell Res. 248:30–43, 1999
Stambolic V., Mak T. W., Woodgett J. R.: Modulation of cellular apoptotic potential: contributions to oncogenesis. Oncogene. 18:6094–6103, 1999
Nagata S.: Apoptosis by death factor. Cell. 88:355–365, 1997
Aggarwal B. B., Vilcek J. Tumore Necrosis Factor: Structure, Function and Mechanism of Action. New York: Marcel Dekker; 1992
Ghosh S., May M. J., Kopp E. B.: NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 16:225–260, 1998
Beg A. A., Baldwin A. S., Jr.: The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 7:2064–2070, 1993
Karin M.: How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene. 18:6867–6874, 1999
Pahl H. L.: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 18:6853–6866, 1999
Chen F. E., Ghosh G.: Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views. Oncogene. 18:6845–6852, 1999
Arends M. J., Wyllie A. H.: Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol. 32:223–254, 1991
Kerr J. F., Wyllie A. H., Currie A. R.: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:239–257, 1972
Clarke P. G., Clarke S.: Historic apoptosis. Nature. 378:230, 1995
Cohen J. J.: Apoptosis. Immunol Today. 14:126–130, 1993
Chinnaiyan A. M., Dixit V. M.: The cell-death machine. Curr Biol. 6:555–562, 1996
McDonnell T. J., Korsmeyer S. J.: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature. 349:254–256, 1991
Thompson C. B.: Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456–1462, 1995
Gilmore T. D., Koedood M., Piffat K. A., White D. W.: Rel/NF-kappaB/IkappaB proteins and cancer. Oncogene. 13:1367–1378, 1996
Cohen G. M.: Caspases: the executioners of apoptosis. Biochem J. 326 ( Pt 1):1–16, 1997
Green D. R.: Apoptotic pathways: paper wraps stone blunts scissors. Cell. 102:1–4, 2000
Bhardwaj A, Aggarwal BB. Receptor-mediated choreography of life and death. J Clin Immunol. 23:317–32, 2003.
Cerretti D. P., Kozlosky C. J., Mosley B., Nelson N., Van Ness K., Greenstreet T. A., March C. J., Kronheim S. R., Druck T., Cannizzaro L. A., et al.: Molecular cloning of the interleukin-1 beta converting enzyme. Science. 256:97–100, 1992
Kaufmann S. H.: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49:5870–5878, 1989
Kaufmann S. H., Desnoyers S., Ottaviano Y., Davidson N. E., Poirier G. G.: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53:3976–3985, 1993
Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S.: A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:43–50, 1998
Song Q., Lees-Miller S. P., Kumar S., Zhang Z., Chan D. W., Smith G. C., Jackson S. P., Alnemri E. S., Litwack G., Khanna K. K., Lavin M. F.: DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. Embo J. 15:3238–3246, 1996
Takahashi A., Alnemri E. S., Lazebnik Y. A., Fernandes-Alnemri T., Litwack G., Moir R. D., Goldman R. D., Poirier G. G., Kaufmann S. H., Earnshaw W. C.: Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA. 93:8395–8400, 1996
Martin S. J., O'Brien G. A., Nishioka W. K., McGahon A. J., Mahboubi A., Saido T. C., Green D. R.: Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem. 270:6425–6428, 1995
Brancolini C., Benedetti M., Schneider C.: Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE-like proteases. Embo J. 14:5179–5190, 1995
Mashima T., Naito M., Fujita N., Noguchi K., Tsuruo T.: Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem Biophys Res Commun. 217:1185–1192, 1995
Casciola-Rosen L., Nicholson D. W., Chong T., Rowan K. R., Thornberry N. A., Miller D. K., Rosen A.: Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med. 183:1957–1964, 1996
Antoku K., Liu Z., Johnson D. E.: Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents. Leukemia. 11:1665–1672, 1997
Widmann C., Gibson S., Johnson G. L.: Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem. 273:7141–7147, 1998
Green D. R., Reed J. C.: Mitochondria and apoptosis. Science. 281:1309–1312, 1998
Susin S. A., Zamzami N., Kroemer G.: Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta. 1366:151–165, 1998
Adams J. M., Cory S.: The Bcl-2 protein family: arbiters of cell survival. Science. 281:1322–1326, 1998
Gross A., McDonnell J. M., Korsmeyer S. J.: BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1899–1911, 1999
Weldon C. B., Burow M. E., Rolfe K. W., Clayton J. L., Jaffe B. M., Beckman B. S.: NF-kappa B-mediated chemoresistance in breast cancer cells. Surgery. 130:143–150, 2001
Sheikh M. S., Fornace A. J., Jr.: Death and decoy receptors and p53-mediated apoptosis. Leukemia. 14:1509–1513, 2000
Ashkenazi A., Dixit V. M.: Death receptors: signaling and modulation. Science. 281:1305–1308, 1998
Smith C. A., Farrah T., Goodwin R. G.: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 76:959–962, 1994
Mukhopadhyay A., Ni J., Zhai Y., Yu G. L., Aggarwal B. B.: Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J Biol Chem. 274:15978–15981, 1999
Haridas V., Shrivastava A., Su J., Yu G. L., Ni J., Liu D., Chen S. F., Ni Y., Ruben S. M., Gentz R., Aggarwal B. B.: VEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth. Oncozene. 18:6496–6504, 1999
Rath P. C., Aggarwal B. B.: TNF-induced signaling in apoptosis. J Clin Immunol. 19:350–364, 1999
Darnay B. G., Aggarwal B. B.: Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors. Ann Rheum Dis. 58Suppl 1:I2–I13, 1999
Wallach D., Varfolomeev E. E., Malinin N. L., Goltsev Y. V., Kovalenko A. V., Boldin M. P.: Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol. 17:331–367, 1999
Beg A. A., Baltimore D.: An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 274:782–784, 1996
Liu Z. G., Hsu H., Goeddel D. V., Karin M.: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell. 87:565–576, 1996
Van Antwerp D. J., Martin S. J., Kafri T., Green D. R., Verma I. M.: Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 274:787–789, 1996
Wang C. Y., Mayo M. W., Baldwin A. S., Jr.: TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science. 274:784–787, 1996
Gilmore T. D.: Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel. Oncogene. 18:6925–6937, 1999
Neiman P. E., Thomas S. J., Loring G.: Induction of apoptosis during normal and neoplastic B-cell development in the bursa of Fabricius. Proc Natl Acad Sci U S A. 88:5857–5861, 1991
Chu Z. L., McKinsey T. A., Liu L., Gentry J. J., Malim M. H., Ballard D. W.: Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci USA. 94:10057–10062, 1997
Khoshnan A., Tindell C., Laux I., Bae D., Bennett B., Nel A. E.: The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J lmmunol. 165:1743–1754, 2000
Stehlik C., de Martin R., Kumabashiri I., Schmid J. A., Binder B. R., Lipp J.: Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med. 188:211–216, 1998
Asso-Bonnet M., Feuillard J., Ferreira V., Bissieres P., Tarantino N., Korner M., Raphael M.: Relationship between IkappaBalpha constitutive expression, TNFalpha synthesis, and apoptosis in EBV-infected lymphoblastoid cells. Oncogene. 17:1607–1615, 1998
Lee K. Y., Chang W., Qiu D., Kao P. N., Rosen G. D.: PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells. J Biol Chem. 274:13451–13455, 1999
Sugiyama H., Savill J. S., Kitamura M., Zhao L., Stylianou E.: Selective sensitization to tumor necrosis factor-alpha-induced apoptosis by blockade of NF-kappaB in primary glomerular mesangial cells. J Biol Chem. 274:19532–19537, 1999
Shao R., Karunagaran D., Zhou B. P., Li K., Lo S. S., Deng J., Chiao P., Hung M. C.: Inhibition of nuclear factor-kappaB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis. J Biol Chem. 272:32739–32742, 1997
Kajino S., Suganuma M., Teranishi F., Takahashi N., Tetsuka T., Ohara H., Itoh M., Okamoto T.: Evidence that de novo protein synthesis is dispensable for anti-apoptotic effects of NF-kappaB. Oncogene. 19:2233–2239, 2000
Javelaud D., Besancon F.: NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B. Oncogene. 20:4365–4372, 2001
Bergmann M. W., Loser P., Dietz R., von Harsdorf R.: Effect of NF-kappa B Inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes. J Mol Cell Cardiol. 33:1223–1232, 2001
Li Z. W., Chu W., Hu Y., Delhase M., Deerinck T., Ellisman M., Johnson R., Karin M.: The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med. 189:1839–1845, 1999
Zong W. X., Farrell M., Bash J., Gelinas C.: v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFalpha-induced cell death. Oncogene. 15:971–980, 1997
Yamit-Hezi A., Dikstein R.: TAFII105 mediates activation of anti-apoptotic genes by NF-kappaB. Embo J. 17:5161–5169, 1998
Shao R., Hu M. C., Zhou B. P., Lin S. Y., Chiao P. J., von Lindern R. H., Spohn B., Hung M. C.: ElA sensitizes cells to tumor necrosis factor-induced apoptosis through inhibition of IkappaB kinases and nuclear factor kappaB activities. J Biol Chem. 274:21495–21498, 1999
Cross J. V., Deak J. C., Rich E. A., Qian Y., Lewis M., Parrott L. A., Mochida K., Gustafson D., Vande Pol S., Templeton D. J.: Quinone reductase inhibitors block SAPK/JNK and NFkappaB pathways and potentiate apoptosis. J Biol Chem. 274:31150–31154, 1999
Foehr E. D., Lin X., O'Mahony A., Geleziunas R., Bradshaw R. A., Greene W. C.: NF-kappa B signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells. J Neurosci. 20:7556–7563, 2000
Wu M., Lee H., Bellas R. E., Schauer S. L., Arsura M., Katz D., FitzGerald M. J., Rothstein T. L., Sherr D. H., Sonenshein G. E.: Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. Embo J. 15:4682–4690, 1996
Arlt A., Vorndamm J., Breitenbroich M., Folsch U. R., Kalthoff H., Schmidt W. E., Schafer H.: Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncozene. 20:859–868, 2001
Qin J. Z., Chaturvedi V., Denning M. F., Choubey D., Diaz M. O., Nickoloff B. J.: Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes. J Biol Chem. 274:37957–37964, 1999
Kolenko V., Bloom T., Rayman P., Bukowski R., Hsi E., Finke J.: Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and-3. J Immunol. 163:590–598, 1999
Kawai H., Yamada Y., Tatsuka M., Niwa O., Yamamoto K., Suzuki F.: Down-regulation of nuclear factor kappaB is required for p53-dependent apoptosis in X-ray-irradiated mouse lymphoma cells and thymocytes. Cancer Res. 59:6038–6041, 1999
Aoki M., Nata T., Morishita R., Matsushita H., Nakagami H., Yamamoto K., Yamazaki K., Nakabayashi M., Ogihara T., Kaneda Y.: Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension. 38:48–55, 2001
Li Y., Zhang W., Mantell L. L., Kazzaz J. A., Fein A. M., Horowitz S.: Nuclear factor-kappaB is activated by hyperoxia but does not protect from cell death. J Biol Chem. 272:20646–20649, 1997
Ginis I., Hallenbeck J. M., Liu J., Spatz M., Jaiswal R., Shohami E.: Tumor necrosis factor and reactive oxygen species cooperative cytotoxicity is mediated via inhibition of NF-kappaB. Mol Med. 6:1028–1041, 2000
Demarchi F., Verardo R., Varnum B., Brancolini C., Schneider C.: Gas6 anti-apoptotic signaling requires NF-kappa B activation. J Biol Chem. 276:31738–31744, 2001
Zechner D., Craig R., Hanford D. S., McDonough P. M., Sabbadini R. A., Glembotski C. C.: MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J Biol Chem. 273:8232–8239, 1998
Baghdiguian S., Martin M., Richard I., Pons F., Astier C., Bourg N., Hay R. T., Chemaly R., Halaby G., Loiselet J., Anderson L. V., Lopez de Munain A., Fardeau M., Mangeat P., Beckmann J. S., Lefrane G.: Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med. 5:503–511, 1999
Trauzold A., Wermann H., Arlt A., Schutze S., Schafer H., Oestern S., Roder C., Ungefroren H., Lampe E., Heinrich M., Walczak H., Kalthoff H.: CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Oncogene. 20:4258–4269, 2001
Kanai M., Konda Y., Nakajima T., Izumi Y., Takeuchi T., Chiba T.: TGF-alpha inhibits apoptosis of murine gastric pit cells through an NF-kappaB-dependent pathway. Gastroenterology. 121:56–67, 2001
Caamano J., Tato C., Cai G., Villegas E. N., Speirs K., Craig L., Alexander J., Hunter C. A.: Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii. J Immunol. 165:5720–5728, 2000
Wang C. Y., Mayo M. W., Korneluk R. G., Goeddel D. V., Baldwin A. S., Jr.: NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAPI and c-IAP2 to suppress caspase-8 activation. Science. 281:1680–1683, 1998
Manna S. K., Zhang H. J., Yan T., Oberley L. W., Aggarwal B. B.: Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem. 273:13245–13254, 1998
Eichholtz-Wirth H., Sagan D.: IkappaB/NF-kappaB mediated cisplatin resistance in HeLa cells after low-dose gamma-irradiation is associated with altered SODD expression. Apoptosis. 5:255–263, 2000
Bertrand F., Desbois-Mouthon C., Cadoret A., Prunier C., Robin H., Capeau J., Atfi A., Cherqui G.: Insulin antiapoptotic signaling involves insulin activation of the nuclear factor kappaB-dependent survival genes encoding tumor necrosis factor receptor-associated factor 2 and manganese-superoxide dismutase. J Biol Chem. 274:30596–30602, 1999
Krikos A., Laherty C. D., Dixit V. M.: Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J Biol Chem. 267:17971–17976, 1992
Opipari A. W., Jr., Hu H. M., Yabkowitz R., Dixit V. M.: The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem. 267:12424–12427, 1992
Hinz M., Krappmann D., Eichten A., Heder A., Scheidereit C., Strauss M.: NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol. 19:2690–2698, 1999
Guttridge D. C., Albanese C., Reuther J. Y., Pestell R. G., Baldwin A. S., Jr.: NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol. 19:5785–5799, 1999
Wang C. Y., Cusack J. C., Jr., Liu R., Baldwin A. S., Jr.: Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med. 5:412–417, 1999
Zong W. X., Edelstein L. C., Chen C., Bash J., Gelinas C.: The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 13:382–387, 1999
de Moissac D., Mustapha S., Greenberg A. H., Kirshenbaum L. A.: Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha. J Biol Chem. 273:23946–23951, 1998
Romashkova J. A., Makarov S. S.: NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature. 401:86–90, 1999
Yang C. H., Murti A., Pfeffer S. R., Kim J. G., Donner D. B., Pfeffer L. M.: Interferon alpha /beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt. J Biol Chem. 276:13756–13761, 2001
Natoli G., Costanzo A., Guido F., Moretti F., Bernardo A., Burgio V. L., Agresti C., Levrero M.: Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2. J Biol Chem. 273:31262–31272, 1998
Levkau B., Scatena M., Giachelli C. M., Ross R., Raines E. W.: Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop. Nat Cell Biol. 1:227–233, 1999
Reuther J. Y., Baldwin A. S., Jr.: Apoptosis promotes a caspase-induced amino-terminal truncation of IkappaBalpha that functions as a stable inhibitor of NF-kappaB. J Biol Chem. 274:20664–20670, 1999
Ravi R., Bedi A., Fuchs E. J.: CD95 (Fas)-induced caspase-mediated proteolysis of NF-kappaB. Cancer Res. 58:882–886, 1998
Kitajima I., Soejima Y., Takasaki I., Beppu H., Tokioka T., Maruyama I.: Ceramide-induced nuclear translocation of NF-kappa B is a potential mediator of the apoptotic response to TNF-alpha in murine clonal osteoblasts. Bone. 19:263–270, 1996
Hu X., Tang M., Fisher A. B., Olashaw N., Zuckerman K. S.: TNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation. J Immunol. 163:3106–3115, 1999
Packham G., Lahti J. M., Fee B. E., Gawn J. M., Coustan-Smith E., Campana D., Doughlas I., Kidd V. J., Ghosh S., Cleveland J. L.: Fas activates NF-kB and induces apoptosis in T-cell lines by signaling pathways distinct from those induced by TNF-a. Cell Death Differ. 4:130–139, 1997
Ivanov V. N., Ronai Z.: p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-kappaB activity and Fas expression. Oncojene. 19:3003–3012, 2000
Dumont A., Hehner S. P., Hofmann T. G., Ueffing M., Droge W., Schmitz M. L.: Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. Oncogene. 18:747–757, 1999
Vollgraf U., Wegner M., Richter-Landsberg C.: Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J Neurochem. 73:2501–2509, 1999
Grey S. T., Arvelo M. B., Hasenkamp W., Bach F. H., Ferran C.: A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J Exp Med. 190:1135–1146, 1999
Bessho R., Matsubara K., Kubota M., Kuwakado K., Hirota H., Wakazono Y., Lin Y. W., Okuda A., Kawai M., Nishikomori R., et al.: Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem Pharmacol. 48:1883–1889, 1994
Stark L. A., Din F. V., Zwacka R. M., Dunlop M. G.: Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. Faseb J. 15:1273–1275, 2001
Gupta R. A., Polk D. B., Krishna U., Israel D. A., Yan F., DuBois R. N., Peek R. M., Jr.: Activation of peroxisome proliferator-activated receptor gamma suppresses nuclear factor kappa B-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells. J Biol Chem. 276:31059–31066, 2001
Lin K. I., Lee S. H., Narayanan R., Baraban J. M., Hardwick J. M., Ratan R. R.: Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J Cell Biol. 131:1149–1161, 1995
Kuhnel F., Zender L., Paul Y., Tietze M. K., Trautwein C., Manns M., Kubicka S.: NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis. J Biol Chem. 275:6421–6427, 2000
Takuma K., Lee E., Kidawara M., Mori K., Kimura Y., Baba A., Matsuda T.: Apoptosis in Ca2 + reperfusion injury of cultured astrocytes: roles of reactive oxygen species and NF-kappaB activation. Eur J Neurosci. 11:4204–4212, 1999
Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., Schwaninger M.: NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med. 5:554–559, 1999
Gil J., Alcami J., Esteban M.: Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. Mol Cell Biol. 19:4653–4663, 1999
Lin K. I., DiDonato J. A., Hoffmann A., Hardwick J. M., Ratan R. R.: Suppression of steady-state, but not stimulus-induced NF-kappaB activity inhibits alphavirus-induced apoptosis. J Cell Biol. 141:1479–1487, 1998
Nakai M., Qin Z. H., Chen J. F., Wang Y., Chase T. N.: Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-kappaB activation. J Neurochem. 74:647–658, 2000
Hettmann T., DiDonato J., Karin M., Leiden J. M.: An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. J Exp Med. 189:145–158, 1999
Bellas R. E., Sonenshein G. E.: Nuclear factor kappaB cooperates with c-Myc in promoting murine hepatocyte survival in a manner independent of p53 tumor suppressor function. Cell Growth Differ. 10:287–294, 1999
Helenius M., Hanninen M., Lehtinen S. K., Salminen A.: Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B. Biochem J. 318 ( Pt 2):603–608, 1996
Ferran C., Stroka D. M., Badrichani A. Z., Cooper J. T., Wrighton C. J., Soares M., Grey S. T., Bach F. H.: A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood. 91:2249–2258, 1998
Zen K., Karsan A., Stempien-Otero A., Yee E., Tupper J., Li X., Eunson T., Kay M. A., Wilson C. B., Winn R. K., Harlan J. M.: NF-kappaB activation is required for human endothelial survival during exposure to tumor necrosis factor-alpha but not to interleukin-1 beta or lipopolysaccharide. J Biol Chem. 274:28808–28815, 1999
Chen S., Guttridge D. C., Tang E., Shi S., Guan K., Wang C. Y.: Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaB-independent bone morphogenetic protein/Smad signaling. J Biol Chem. 276:39259–39263, 2001
Jiang Y., Woronicz J. D., Liu W., Goeddel D. V.: Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science. 283:543–546, 1999
Okura T., Gong L., Kamitani T., Wada T., Okura I., Wei C. F., Chang H. M., Yeh E. T.: Protection against Fas/APO-1-and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J lmmunol. 157:4277–4281, 1996
Scaffidi C., Schmitz I., Krammer P. H., Peter M. E.: The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem. 274:1541–1548, 1999
Hall J. L., Wang X., Van A., Zhao Y., Gibbons G. H.: Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappab-independent and-dependent pathways. Circ Res. 88:1247–1253, 2001
Tabata M., Tabata R., Grabowski D. R., Bukowski R. M., Ganapathi M. K., Ganapathi R.: Roles of NF-kappaB and 26 S proteasome in apoptotic cell death induced by topoisomerase I and II poisons in human nonsmall cell lung carcinoma. J Biol Chem. 276:8029–8036, 2001
Herrmann J. L., Beham A. W., Sarkiss M., Chiao P. J., Rands M. T., Bruckheimer E. M., Brisbay S., McDonnell T. J.: Bcl-2 suppresses apoptosis resulting from disruption of the NF-kappa B survival pathway. Exp Cell Res. 237:101–109, 1997
Lallemand F., Mazars A., Prunier C., Bertrand F., Kornprost M., Gallea S., Roman-Roman S., Cherqui G., Atfi A.: Smad7 inhibits the survival nuclear factor kappaB and potentiates apoptosis in epithelial cells. Oncogene. 20:879–884, 2001
Besancon F., Atfi A., Gespach C., Cayre Y. E., Bourgeade M. F.: Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor beta fusion protein. Proc Natl Acad Sci USA. 95:8081–8086, 1998
You M., Ku P. T., Hrdlickova R., Bose H. R., Jr.: ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein. Mol Cell Biol. 17:7328–7341, 1997
Oya M., Ohtsubo M., Takayanagi A., Tachibana M., Shimizu N., Murai M.: Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells. Oncogene. 20:3888–3896, 2001
Franek W. R., Horowitz S., Stansberry L., Kazzaz J. A., Koo H. C., Li Y., Arita Y., Davis J. M., Mantell A. S., Scott W., Mantell L. L.: Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells. J Biol Chem. 276:569–575, 2001
Hofer-Warbinek R., Schmid J. A., Stehlik C., Binder B. R., Lipp J., de Martin R.: Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J Biol Chem. 275:22064–22068, 2000
Slater A. F., Kimland M., Jiang S. A., Orrenius S.: Constitutive nuclear NF kappa B/rel DNA-binding activity of rat thymocytes is increased by stimuli that promote apoptosis, but not inhibited by pyrrolidine dithiocarbamate. Biochem J. 312 ( Pt 3):833–838, 1995
Ashikawa K., Shishodia S., Fokt I., Priebe W., Aggarwal B. B.: Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues. Biochem Pharmacol. 67:353–364, 2004
Bian X., McAllister-Lucas L. M., Shao F., Schumacher K. R., Feng Z., Porter A. G., Castle V. P., Opipari A. W., Jr.: NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J Biol Chem. 276:48921–48929, 2001
Segev D. L., Ha T. U., Tran T. T., Kenneally M., Harkin P., Jung M., MacLaughlin D. T., Donahoe P. K., Maheswaran S.: Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway. J Biol Chem. 275:28371–28379, 2000
Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword Nat Rev Immunol. 2003 Sep; 3(9):745–56.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Aggarwal, B.B., Takada, Y. (2005). Pro-apototic and Anti-apoptotic Effects of Tumor Necrosis Factor in Tumor Cells. In: Platanias, L.C. (eds) Cytokines and Cancer. Cancer Treatment and Research, vol 126. Springer, Boston, MA. https://doi.org/10.1007/0-387-24361-5_5
Download citation
DOI: https://doi.org/10.1007/0-387-24361-5_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-24360-3
Online ISBN: 978-0-387-24361-0
eBook Packages: MedicineMedicine (R0)